Sutro Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sutro Biopharma using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.67 | $-0.37 | -81.1 % |
| Q2 | 2025-08-07 | $-0.14 | $-0.47 | 70.2 % |
| Q1 | 2025-05-08 | $-0.91 | $-0.92 | 1.09 % |
| Q4 | 2025-03-13 | $-0.89 | $-0.95 | 6.32 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $9.69M | $8.81M | 10.1 % |
| Q2 | 2025-08-07 | $63.75M | $15.03M | 324.1 % |
| Q1 | 2025-05-08 | $17.40M | $9.00M | 93.3 % |
| Q4 | 2025-03-13 | $14.81M | $12.18M | 21.6 % |
Sutro Biopharma (STRO) is scheduled to report earnings on March 12, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $-0.67, which missed the estimate of $-0.37.
The Actual Revenue was $9.7M, which beat the estimate of $8.8M.
Browse earnings estimates, EPS, and revenue on all stocks.